At the level of BM, Uchida et al. observed lower levels of CD34+ cells in SCD patients treated with HU as compared to “steady-state” or SCD patients without treatment [9], suggesting that some of the discrepancies in the previous reports might have been caused by the lack of stratification of the patients by treatment modality. The gene discussed is CD34; the disease is Schnyder corneal dystrophy.